HYPERALPHALIPOPROTEINEMIA 1
|
disease |
|
Disease or Syndrome
|
9
|
4
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Hypoalphalipoproteinemias
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
20
|
7
|
0.020 |
None |
1.000 |
2 |
1
|
2006 |
2008 |
Cholesteryl Ester Transfer Protein Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
22
|
5
|
0.020 |
None |
1.000 |
2 |
1
|
2008 |
2009 |
Dyslipoproteinemias
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Gambling, Pathological
|
disease |
Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
26
|
9
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Lipids measurement
|
group |
|
Laboratory Procedure
|
27
|
53
|
0.100 |
None |
1.000 |
2 |
1
|
2009 |
2012 |
Periodontal Pocket
|
disease |
Stomatognathic Diseases
|
Anatomical Abnormality
|
28
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Insulin Sensitivity
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Regurgitation
|
phenotype |
|
Sign or Symptom
|
66
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Carotid Artery Diseases
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
69
|
6
|
0.020 |
None |
1.000 |
2 |
1
|
2010 |
2015 |
Memory dysfunction
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
70
|
3
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Holoprosencephaly
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Congenital Abnormality
|
109
|
45
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Dry Eye Syndromes
|
disease |
Eye Diseases
|
Disease or Syndrome
|
156
|
1
|
0.200 |
None |
|
0 |
|
|
|
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Aortic Valve Stenosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
234
|
19
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Atherosclerotic lesion
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
253
|
|
0.030 |
None |
1.000 |
3 |
|
2003 |
2009 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Periodontal Diseases
|
group |
Stomatognathic Diseases
|
Disease or Syndrome
|
326
|
22
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hypertriglyceridemia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
340
|
169
|
0.310 |
None |
1.000 |
1 |
|
2003 |
2003 |
Pulmonary Emphysema
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
352
|
64
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Blindness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
393
|
34
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
6
|
2012 |
2012 |
Dyslipidemias
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
471
|
184
|
0.310 |
None |
1.000 |
2 |
|
2007 |
2018 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
2 |
3
|
2012 |
2017 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
3
|
2012 |
2012 |